trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['trastuzumab', 'mbc', 'bcsm']
trastuzumab deruxtecan is new standard of care for her2-low mbc #bcsm #asco22
SVP, Content @MJHLifeSciences. Focused on creating innovative, expert-driven content @OncLive @MedEconomics @AJMC_Journal @Pharmacy_Times @MDMagazine plus more